Research and Treatment

Research & Treatment

Telemedicine can bridge the distance between doctor and patients.Read More
Updates on Daklinza, Technivie, and the ACE910 trialRead More
NHF is committed to the training and support of clinician-researchers in hematology.Read More
NHF awarded 5 JGP Fellowships in 2014.Read More
There are times when less really is more. With the June 6, 2014, US Food and Drug Administration (FDA) approval...Read More
Progress. For years, the bleeding disorders community has been waiting for meaningful progress for a greater understanding of hemophilia, for...Read More
A six-year study by the US Centers for Disease Control and Prevention (CDC) of patients with inhibitors, antibodies to infused...Read More
HemAware is conducting a series of interviews with recipients of the NHF-Shire Clinical Fellowship . It is funded through the...Read More
HemAware is conducting a series of interviews with recipients of the NHF-Shire Clinical Fellowship . It is funded through the...Read More
HemAware is conducting a series of interviews with recipients of the NHF-Shire Clinical Fellowship. It is funded through the generous...Read More
When the US Food and Drug Administration (FDA) approved Tivicay ® (dolutegravir), a new drug to treat HIV, in August...Read More
Update, November 2014: The St. Jude/UCL gene therapy trial now has data from all 10 participants, to be published in...Read More
Chat Icon
Need Info? Ask NHF!
Contact HANDI, NHF's resource center for additional information on bleeding disorders.